<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR125">
 <label>125.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Roman</surname>
    <given-names>VR</given-names>
   </name>
   <name>
    <surname>Jensen</surname>
    <given-names>KJ</given-names>
   </name>
   <name>
    <surname>Jensen</surname>
    <given-names>SS</given-names>
   </name>
   <name>
    <surname>Leo-Hansen</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Jespersen</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>da Silva</surname>
    <given-names>Te D</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Therapeutic vaccination using cationic liposome-adjuvanted HIV type 1 peptides representing HLA-supertype-restricted subdominant T cell epitopes: safety, immunogenicity, and feasibility in Guinea-Bissau</article-title>
  <source>AIDS Res Hum Retrovir</source>
  <year>2013</year>
  <volume>29</volume>
  <issue>11</issue>
  <fpage>1504</fpage>
  <lpage>1512</lpage>
  <pub-id pub-id-type="doi">10.1089/aid.2013.0076</pub-id>
  <?supplied-pmid 23634822?>
  <pub-id pub-id-type="pmid">23634822</pub-id>
 </element-citation>
</ref>
